{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:39:35Z","timestamp":1774039175387,"version":"3.50.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ando.2015.03.022","type":"journal-article","created":{"date-parts":[[2015,4,25]],"date-time":"2015-04-25T23:10:59Z","timestamp":1430003459000},"page":"153-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Primary hyperparathyroidism and vitamin D deficiency"],"prefix":"10.1016","volume":"76","author":[{"given":"Fritz-Line","family":"V\u00e9layoudom-C\u00e9phise","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"W\u00e9meau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2015.03.022_bib0005","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1210\/jcem-8-8-637","article-title":"A page out of the history of hyperparathyroidism","volume":"8","author":"Albright","year":"1948","journal-title":"J Clin Endocrinol Metab"},{"issue":"21","key":"10.1016\/j.ando.2015.03.022_bib0010","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM196605262742105","article-title":"The study of hyperparathyroidism at the Massachusetts General Hospital","volume":"274","author":"Cope","year":"1966","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2015.03.022_bib0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","article-title":"Hyperparathyroidism","volume":"374","author":"Fraser","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2015.03.022_bib0020","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1106636","article-title":"Clinical practice. Primary hyperparathyroidism","volume":"365","author":"Marcocci","year":"2011","journal-title":"N Engl J Med"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.ando.2015.03.022_bib0025","first-page":"N75","article-title":"Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: a global perspective","volume":"17","author":"Rao","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2015.03.022_bib0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S2213-8587(13)70083-4","article-title":"Subclinical and asymptomatic parathyroid disease: implications of emerging data","volume":"1","author":"Macfarlane","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ando.2015.03.022_bib0035","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0002-9343(99)00294-6","article-title":"The effects of vitamin D insufficiency in patients with primary hyperparathyroidism","volume":"107","author":"Silverberg","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.ando.2015.03.022_bib0040","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1530\/EJE-11-0589","article-title":"Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism","volume":"165","author":"Bollerslev","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2015.03.022_bib0045","first-page":"129","article-title":"When should we measure vitamin D concentration in clinical practice?","volume":"243","author":"Souberbielle","year":"2012","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"10.1016\/j.ando.2015.03.022_bib0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/cen.12206","article-title":"What predicts adverse outcomes in untreated primary hyperparathyroidism? The Parathyroid Epidemiology and Audit Research Study (PEARS)","volume":"79","author":"Yu","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.03.022_bib0055","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/0002-9343(69)90083-7","article-title":"Primary hyperparathyroidism associated with nutritional osteomalacia","volume":"46","author":"Vaishava","year":"1969","journal-title":"Am J Med"},{"key":"10.1016\/j.ando.2015.03.022_bib0060","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/bmj.281.6241.647","article-title":"Severe hypophosphataemic osteomalacia with primary hyperparathyroidism","volume":"281","author":"Woodhead","year":"1980","journal-title":"Br Med J"},{"key":"10.1016\/j.ando.2015.03.022_bib0065","first-page":"505","article-title":"Formes ost\u00e9omalaciques de l\u2019hyperparathyro\u00efdie primitive","volume":"55","author":"Duquesnoy","year":"1988","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"10.1016\/j.ando.2015.03.022_bib0070","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJM198002213020801","article-title":"The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism","volume":"302","author":"Broadus","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2015.03.022_bib0075","first-page":"250","article-title":"Treatment with active vitamin D (alphacalcidol) in patients with mild primary hyperparathyroidism","volume":"120","author":"Lind","year":"1989","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.ando.2015.03.022_bib0080","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1210\/jc.2013-3978","article-title":"Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial","volume":"9","author":"Rolighed","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.022_bib0085","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2015.03.022_bib0090","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J Clin Endocrinol Metab. 2011;"},{"key":"10.1016\/j.ando.2015.03.022_bib0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jsbmb.2010.03.077","article-title":"Vitamin D and primary hyperparathyroidism (PHPT)","volume":"121","author":"Souberbielle","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ando.2015.03.022_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/729670","article-title":"Omega-3 Fatty acids and vitamin d in cardiology","author":"G\u00fcttler","year":"2012","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.ando.2015.03.022_bib0105","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/cen.12398","article-title":"Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature","volume":"80","author":"Shah","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.03.022_bib0110","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1046\/j.1365-2796.2000.00595.x","article-title":"Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited","volume":"247","author":"Glerup","year":"2000","journal-title":"J Intern Med"},{"key":"10.1016\/j.ando.2015.03.022_bib0115","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s00125-012-2544-y","article-title":"Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies","volume":"55","author":"Forouhi","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.ando.2015.03.022_bib0120","series-title":"Apports nutritionnels conseill\u00e9s pour la population fran\u00e7aise","first-page":"229","author":"Martin","year":"2001"},{"key":"10.1016\/j.ando.2015.03.022_bib0125","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s00198-009-0954-6","article-title":"Global vitamin D status and determinants of hypovitaminosis D","volume":"20","author":"Mithal","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ando.2015.03.022_bib0130","series-title":"Dietary Reference Intakes for Calcium and Vitamin D. Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium","author":"Ross","year":"2011"},{"key":"10.1016\/j.ando.2015.03.022_bib0135","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1359\/jbmr.080608","article-title":"Serum vitamin D measurement may not reflect what you give to your patients","volume":"23","author":"Cavalier","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2015.03.022_bib0140","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s001980050030","article-title":"Prevalence of vitamin D insufficiency in an adult normal population","volume":"7","author":"Chapuy","year":"1997","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ando.2015.03.022_bib0145","first-page":"F157","article-title":"Vitamin D","volume":"277","author":"Brown","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ando.2015.03.022_bib0150","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0002-9343(74)90812-2","article-title":"Parathyroid function in human vitamin D deficiency and vitamin D deficiency in primary hyperparathyroidism","volume":"56","author":"Lumb","year":"1974","journal-title":"Am J Med"},{"key":"10.1016\/j.ando.2015.03.022_bib0155","first-page":"1474","article-title":"Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid","volume":"45","author":"Hosoi","year":"1985","journal-title":"Cancer Res"},{"key":"10.1016\/j.ando.2015.03.022_bib0160","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S8756-3282(02)00866-9","article-title":"Relationship between serum 25-hydroxyvitamin D and bone resorption markers in vitamin D insufficiency","volume":"31","author":"Jesudason","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.ando.2015.03.022_bib0165","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/edrv.22.4.0437","article-title":"Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications","volume":"22","author":"Lips","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2015.03.022_bib0170","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1530\/eje.0.1480403","article-title":"Decrease in vitamin D receptor and calcium-sensing receptor in highly proliferative parathyroid adenomas","volume":"148","author":"Yano","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2015.03.022_bib0175","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1677\/erc.1.00970","article-title":"Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors","volume":"12","author":"Corbetta","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2015.03.022_bib0180","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejim.2011.07.008","article-title":"Vitamin D status in primary hyperparathyroidism","volume":"23","author":"Saliba","year":"2012","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ando.2015.03.022_bib0185","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2265.2005.02371.x","article-title":"Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism","volume":"63","author":"Moosgaard","year":"2005","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2015.03.022_bib0190","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF03344140","article-title":"A very high incidence of low 25-hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism","volume":"29","author":"Boudou","year":"2006","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.ando.2015.03.022_bib0195","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1016\/j.lpm.2010.08.005","article-title":"La moiti\u00e9 des patients atteints d\u2019hyperparathyro\u00efdies primaires ont un d\u00e9ficit en vitamine D aggravant l\u2019atteinte osseuse","volume":"40","author":"V\u00e9layoudom-C\u00e9phise","year":"2011","journal-title":"Presse Med"},{"key":"10.1016\/j.ando.2015.03.022_bib0200","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ncpendmet0265","article-title":"The diagnosis and management of asymptomatic primary hyperparathyroidism","volume":"2","author":"Silverberg","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.022_bib0205","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1067\/msy.2001.118377","article-title":"Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25 years","volume":"130","author":"Lundgren","year":"2001","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2015.03.022_bib0210","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/bmj.327.7414.530","article-title":"Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism","volume":"327","author":"Vestergaard","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ando.2015.03.022_bib0215","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(97)00270-2","article-title":"3rd Survival after the diagnosis of hyperparathyroidism: a population-based study","volume":"104","author":"Wermers","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.ando.2015.03.022_bib0220","first-page":"1","article-title":"Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979","volume":"102","author":"Palm\u00e9r","year":"1987","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2015.03.022_bib0225","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2362.1998.00289.x","article-title":"Increased risk of death from primary hyperparathyroidism\u00a0\u2013\u00a0an update","volume":"28","author":"Hedb\u00e4ck","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ando.2015.03.022_bib0230","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s002689910092","article-title":"Outcome after surgery for primary hyperparathyroidism: ten-year prospective follow-up study","volume":"24","author":"Walgenbach","year":"2000","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2015.03.022_bib0235","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0039-6060(97)90216-6","article-title":"Survival after surgical treatment for primary hyperparathyroidism","volume":"122","author":"S\u00f6reide","year":"1997","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2015.03.022_bib0240","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2796.1991.tb00403.x","article-title":"Cardiovascular risk factors in primary hyperparathyroidism: a 15-year follow-up of operated and unoperated cases","volume":"230","author":"Lind","year":"1991","journal-title":"J Intern Med"},{"key":"10.1016\/j.ando.2015.03.022_bib0245","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0039-6060(98)70038-8","article-title":"Case-control study on symptoms and signs of \u201casymptomatic\u201d primary hyperparathyroidism","volume":"124","author":"Lundgren","year":"1998","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2015.03.022_bib0250","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.0300-0664.2001.01468.x","article-title":"Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years","volume":"56","author":"Hagstr\u00f6m","year":"2002","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2015.03.022_bib0255","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1210\/jc.2004-1400","article-title":"Arterial stiffness in mild primary hyperparathyroidism","volume":"90","author":"Rubin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.022_bib0260","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2265.2009.03558.x","article-title":"Correlation between plasma calcium, parathyroid hormone (PTH) and the metabolic syndrome (MetS) in a community-based cohort of men and women","volume":"71","author":"Ahlstr\u00f6m","year":"2009","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2015.03.022_bib0265","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1053\/meta.2000.17708","article-title":"Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level","volume":"49","author":"Chiu","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.ando.2015.03.022_bib0270","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/dmrr.199","article-title":"Coincident diabetes mellitus and primary hyperparathyroidism","volume":"17","author":"Taylor","year":"2001","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.ando.2015.03.022_bib0275","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2362.1983.tb00116.x","article-title":"Diabetes mellitus, glucose tolerance and insulin response to glucose in patients with primary hyperparathyroidism before and after parathyroidectomy","volume":"13","author":"Ljunghall","year":"1983","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ando.2015.03.022_bib0280","doi-asserted-by":"crossref","first-page":"745","DOI":"10.7326\/0003-4819-121-10-199411150-00003","article-title":"Body weight and bone mineral density in postmenopausal women with primary hyperparathyroidism","volume":"121","author":"Grey","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ando.2015.03.022_bib0285","first-page":"580","article-title":"Glucose and lipoprotein metabolism in primary hyperparathyroidism. Effects of parathyroidectomy","volume":"89","author":"Ljunghall","year":"1978","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.ando.2015.03.022_bib0290","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","article-title":"Vitamin D deficiency and risk of cardiovascular disease","volume":"29","author":"Wang","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ando.2015.03.022_bib0295","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/HYPERTENSIONAHA.107.087288","article-title":"Plasma 25-hydroxyvitamin D levels and risk of incident hypertension","volume":"49","author":"Forman","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ando.2015.03.022_bib0300","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1111\/j.1532-5415.2009.02359.x","article-title":"Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older US adults","volume":"57","author":"Ginde","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ando.2015.03.022_bib0305","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/ATVBAHA.108.165886","article-title":"Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004","volume":"28","author":"Melamed","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ando.2015.03.022_bib0310","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2265.2006.02633.x","article-title":"Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients","volume":"65","author":"Targher","year":"2006","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2015.03.022_bib0315","first-page":"H1739","article-title":"Trophic effects of catecholamines and parathyroid hormone on adult ventricular cardiomyocytes","volume":"263","author":"Schl\u00fcter","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ando.2015.03.022_bib0320","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1067\/msy.2099.101422","article-title":"Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy","volume":"126","author":"Nilsson","year":"1999","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2015.03.022_bib0325","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2265.2010.03909.x","article-title":"Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism","volume":"74","author":"Persson","year":"2011","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2015.03.022_bib0330","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1210\/jc.2011-0238","article-title":"Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers","volume":"96","author":"Farahnak","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.022_bib0335","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1210\/jc.2009-2072","article-title":"Cardiac structure and diastolic function in mild primary hyperparathyroidism","volume":"95","author":"Walker","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.022_bib0340","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ando.2015.03.022_bib0345","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00268-002-6541-z","article-title":"Cardiovascular events before and after surgery for primary hyperparathyroidism","volume":"27","author":"Vestergaard","year":"2003","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2015.03.022_bib0350","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/ajh\/1.4.397","article-title":"Hypertension in primary hyperparathyroidism\u00a0\u2013\u00a0reduction of blood pressure by long-term treatment with vitamin D (alphacalcidol). A double-blind, placebo-controlled study","author":"Lind","year":"1988","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ando.2015.03.022_bib0355","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3945\/ajcn.111.031070","article-title":"Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis","volume":"95","author":"Tripkovic","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ando.2015.03.022_bib0360","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1210\/jc.2004-1772","article-title":"Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency","volume":"90","author":"Grey","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.022_bib0365","first-page":"3541","article-title":"Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism","volume":"85","author":"Kantorovich","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.022_bib0370","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.surg.2008.06.032","article-title":"Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial?","volume":"144","author":"Grubbs","year":"2008","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2015.03.022_bib0375","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/EJE-08-0901","article-title":"Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D","volume":"161","author":"Tucci","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2015.03.022_bib0380","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12020-009-9211-1","article-title":"Biochemical effects of calcifediol supplementation in mild, asymptomatic, hyperparathyroidism with concomitant vitamin D deficiency","volume":"36","author":"Isidro","year":"2009","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2015.03.022_bib0385","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/10408390701764468","article-title":"What is next for the dietary reference intakes for bone metabolism related nutrients beyond calcium: phosphorus, magnesium, vitamin D, and fluoride?","volume":"49","author":"Bergman","year":"2009","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.ando.2015.03.022_bib0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2009.08.020","article-title":"Regulation of vitamin D receptor function in MEN1-related parathyroid adenomas","volume":"313","author":"Dreijerink","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ando.2015.03.022_bib0395","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Eastell","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.022_bib0400","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.022_bib0405","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1210\/jc.2014-1417","article-title":"Medical management of primary hyperparathyroidism: proceedings of the Fourth International Workshop on the management of asymptomatic primary hyperparathyroidism","volume":"99","author":"Marcocci","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.022_bib0410","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1210\/jc.2014-1415","article-title":"Current Issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Silverberg","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.022_bib0415","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1210\/jc.2014-2000","article-title":"The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Udelsman","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.03.022_bib0420","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0003-4266(06)72533-1","article-title":"Prise en charge de l\u2019hyperparathyro\u00efdie primaire asymptomatique","volume":"67","author":"Calzada-Nocaudie","year":"2006","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.ando.2015.03.022_bib0425","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.lpm.2011.04.001","article-title":"La vitamine D chez l\u2019adulte\u00a0: recommandations du GRIO","volume":"40","author":"Benhamou","year":"2011","journal-title":"Presse Med"}],"updated-by":[{"DOI":"10.1016\/j.ando.2015.06.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000}}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426615000438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426615000438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:48:44Z","timestamp":1757717324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426615000438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0003426615000438"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2015.03.022","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ando.2015.06.001","asserted-by":"object"}]},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary hyperparathyroidism and vitamin D deficiency","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2015.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}